A

Amneal Intermediate Inc
NASDAQ:AMRX

Watchlist Manager
Amneal Intermediate Inc
NASDAQ:AMRX
Watchlist
Price: 8.46 USD -2.76% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
Amneal Intermediate Inc?
Write Note

Amneal Intermediate Inc
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Amneal Intermediate Inc
Other Current Liabilities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
A
Amneal Intermediate Inc
NASDAQ:AMRX
Other Current Liabilities
$84.3m
CAGR 3-Years
123%
CAGR 5-Years
37%
CAGR 10-Years
13%
Johnson & Johnson
NYSE:JNJ
Other Current Liabilities
$4.3B
CAGR 3-Years
26%
CAGR 5-Years
7%
CAGR 10-Years
11%
Bristol-Myers Squibb Co
NYSE:BMY
Other Current Liabilities
$5B
CAGR 3-Years
10%
CAGR 5-Years
25%
CAGR 10-Years
10%
Pfizer Inc
NYSE:PFE
Other Current Liabilities
$24.2B
CAGR 3-Years
-2%
CAGR 5-Years
9%
CAGR 10-Years
7%
Merck & Co Inc
NYSE:MRK
Other Current Liabilities
$5.5B
CAGR 3-Years
28%
CAGR 5-Years
21%
CAGR 10-Years
9%
Eli Lilly and Co
NYSE:LLY
Other Current Liabilities
$5.4B
CAGR 3-Years
11%
CAGR 5-Years
13%
CAGR 10-Years
4%

See Also

What is Amneal Intermediate Inc's Other Current Liabilities?
Other Current Liabilities
84.3m USD

Based on the financial report for Dec 31, 2023, Amneal Intermediate Inc's Other Current Liabilities amounts to 84.3m USD.

What is Amneal Intermediate Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
13%

Over the last year, the Other Current Liabilities growth was -23%. The average annual Other Current Liabilities growth rates for Amneal Intermediate Inc have been 123% over the past three years , 37% over the past five years , and 13% over the past ten years .

Back to Top